Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth A Helmink

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cancer Cell|April 11, 2018
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer ImmunotherapyVancheswaran Gopalakrishnan, Beth A Helmink, Christine N Spencer, et al.
Surgical Oncology Clinics of North America|March 26, 2016
Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas CancerBeth A Helmink, Rebecca A Snyder, Kamran Idrees, et al.
Nature Medicine|March 8, 2019
The microbiome, cancer, and cancer therapyBeth A Helmink, M A Wadud Khan, Amanda Hermann, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2023
Utility of Circulating Tumor DNA in Appendiceal TumorsNeal Bhutiani, Beth A Helmink, Mohammad Zeineddine, et al.
Public Health Nutrition|December 17, 2021
Community-based management of acute malnutrition for infants under 6 months of age is safe and effective: analysis of operational dataMaeve M Woeltje, Anastasia B Evanoff, Beth A Helmink, et al.
Cell Cycle (Georgetown, Tex.)|November 24, 2019
DNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genesCynthia L Innes, Jill E Hesse, Abigail J Morales, et al.
BMC Genomics|March 19, 2013
DNA damage activates a complex transcriptional response in murine lymphocytes that includes both physiological and cancer-predisposition programsCynthia L Innes, Jill E Hesse, Stela S Palii, et al.
Annals of Surgical Oncology|September 13, 2023
Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal NeoplasmsMichael G White, Neal Bhutiani, Beth A Helmink, et al.
Annals of Surgical Oncology|August 25, 2023
Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard ProtocolsNeal Bhutiani, Michael G White, Bradford J Kim, et al.
Surgical Oncology Insight|July 31, 2025
Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burdenPaula Marincola Smith, Ashlee Seldomridge, Yi-Ju Chiang, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cancer Cell|April 11, 2018
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer ImmunotherapyVancheswaran Gopalakrishnan, Beth A Helmink, Christine N Spencer, et al.
Surgical Oncology Clinics of North America|March 26, 2016
Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas CancerBeth A Helmink, Rebecca A Snyder, Kamran Idrees, et al.
Nature Medicine|March 8, 2019
The microbiome, cancer, and cancer therapyBeth A Helmink, M A Wadud Khan, Amanda Hermann, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2023
Utility of Circulating Tumor DNA in Appendiceal TumorsNeal Bhutiani, Beth A Helmink, Mohammad Zeineddine, et al.
Public Health Nutrition|December 17, 2021
Community-based management of acute malnutrition for infants under 6 months of age is safe and effective: analysis of operational dataMaeve M Woeltje, Anastasia B Evanoff, Beth A Helmink, et al.
Cell Cycle (Georgetown, Tex.)|November 24, 2019
DNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genesCynthia L Innes, Jill E Hesse, Abigail J Morales, et al.
BMC Genomics|March 19, 2013
DNA damage activates a complex transcriptional response in murine lymphocytes that includes both physiological and cancer-predisposition programsCynthia L Innes, Jill E Hesse, Stela S Palii, et al.
Annals of Surgical Oncology|September 13, 2023
Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal NeoplasmsMichael G White, Neal Bhutiani, Beth A Helmink, et al.
Annals of Surgical Oncology|August 25, 2023
Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard ProtocolsNeal Bhutiani, Michael G White, Bradford J Kim, et al.
Surgical Oncology Insight|July 31, 2025
Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burdenPaula Marincola Smith, Ashlee Seldomridge, Yi-Ju Chiang, et al.
Pageof 5